Lilly and Hims & Hers expand access to FDA-approved Lilly medicines
The agreement brings together Lilly’s obesity medicines and Hims & Hers’ consumer platform.
The agreement brings together Lilly’s obesity medicines and Hims & Hers’ consumer platform.
For added convenience, customers can also shop eligible items through 1 Hour Delivery and 30 Minute Pickup where available, giving them more ways to tackle last-minute needs without missing the celebration.
Baker succeeds Mark Baum building on FMI’s industry collaboration efforts,
Florida health plan targets 30,000 members by 2027, initially focusing on diabetes and obesity management.
TikTok Shop LIVE emerges as a new holiday shopping channel for retailers.
The company is bringing together its specialty businesses under one leader, Richard Tremonte.
Dual recertification means core XiFin production infrastructure for revenue cycle and pharmacy carries a current, independently assessed certification
athenahealth is expanding its Sage AI assistant across charts, billing, analytics and support to streamline workflows and reduce administrative work.
Culmination of 18 months of industry bonversations delivers updated data and new insights on the pharma sdvertising landscape
The new business boosts the development of AI-powered robotics solutions for warehouse automation and intelligent fulfillment processes.
CORE7 for Kids was developed with individual ingredient amounts evaluated for growing children.
New mini-pitch at Clarendon Elementary School will support student wellness and expand access to soccer for students, families and the broader Secaucus community.
The company hosted a Halloween-themed celebration at the New Haven chapter house.
As diabetes treatments and monitoring technologies advance, widespread misconceptions about the condition and medication use highlight the importance of accurate information, individualized care and ongoing support.
The combined company now includes 10 billion-dollar brands and serves consumers across multiple life stages and health needs
Camber's Raltegravir is backed by a copay program, allowing eligible patients to pay $0 out-of-pocket.